Aptose Biosciences Stock Today
| APTO Stock | USD 3.81 0.05 1.33% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Aptose Biosciences is selling at 3.81 as of the 20th of March 2025; that is 1.33 percent increase since the beginning of the trading day. The stock's open price was 3.76. Aptose Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of February 2025 and ending today, the 20th of March 2025. Click here to learn more.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada. The company has 2.14 M outstanding shares of which 2.25 M shares are presently shorted by private and institutional investors with about 0.23 trading days to cover. More on Aptose Biosciences
Moving together with Aptose Stock
Moving against Aptose Stock
Aptose Stock Highlights
| Chairman, CEO and Pres | William Rice |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Aptose Biosciences (APTO) is traded on NASDAQ Exchange in USA. It is located in 251 Consumers Road, Toronto, ON, Canada, M2J 4R3 and employs 35 people. Aptose Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.19 M. Aptose Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.14 M outstanding shares of which 2.25 M shares are presently shorted by private and institutional investors with about 0.23 trading days to cover.
Aptose Biosciences currently holds about 62.41 M in cash with (44.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68.
Check Aptose Biosciences Probability Of Bankruptcy
Ownership AllocationAptose Biosciences shows 5.71 percent of its outstanding shares held by insiders and 7.79 percent owned by other corporate entities.
Check Aptose Ownership Details
Aptose Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aptose Biosciences market risk premium is the additional return an investor will receive from holding Aptose Biosciences long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (7.61) |
Aptose Stock Against Markets
Aptose Biosciences Corporate Management
| Brooks MBA | VP Controller | Profile | |
| Philippe Ledru | Senior Officer | Profile | |
| Janet CA | VP Fin | Profile | |
| Rafael MD | Senior Officer | Profile | |
| Roger BSc | Vice Operations | Profile | |
| Marc Wiles | Senior Affairs | Profile |
Already Invested in Aptose Biosciences?
The danger of trading Aptose Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aptose Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aptose Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aptose Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.